PSI’s “Impact”: Shifting Into High Gear on FP2020 Goals — The Critical Role of Implants and Other LARCs
Katherine Thanel, lead behavioral health planner at J&M Global Solutions, discusses results from a market survey that examined “market composition, trends in product availability, and pricing” of family planning methods, including long-acting reversible contraceptives (LARCs), in three study countries: Ethiopia, Nigeria, and the Democratic Republic of Congo. Thanel concludes, “As we approach 2020, it is imperative that investment in LARCs, especially implants, is prioritized” (4/10).